I-10% Enrofloxacin Oral Solution
.png)
.png)
.png)
.png)
Ukwakheka
I-100ml iqukethe i-10g Enrofloxacin
Ukubonakala
Lo mkhiqizo cishe awunawo umbala kuphuzi okhanyayo ophuzi
Isenzo samakhemisi
I-Emppagliflozin i-bactericidal ebanzi ebanzi enikezelwe ama-fluoroquicolone. Kunomphumela omuhle ku-Escherhichia Coli, Salmonella, Klebsoella, Brucebla, Peteurolla, I-Actsobacillothrix, iStaphylococcus aureus, MyCoplasma, ne-Chlamydia, a abuthakathaka Umphumela we-pseudomonas aeruginosa ne-streptococcus, kanye nomphumela obuthakathaka kumagciwane anaerobic. Inomphumela obalulekile we-antibacterial e-antibacterial kuma-bacterium atholakalayo. Indlela ye-antibacterial yokusebenza kwalo mkhiqizo ukuvimba i-bacterial dna gne, iphathezele ukuphindaphinda, ukuphrinta nokulungisa kanye nokubuyiselwa kabusha kwe-bacterial DNA, futhi amagciwane awakwazi ukukhula futhi aphinde athole.
Pharmacokinetics
Lo mkhiqizo ugxile kahle ngemuva kokuphathwa ngomlomo ezilwaneni eziningi. I-Bioavailability of Administration Oral Inkukhu ingu-62.2% ~ 84%, esatshalaliswa kabanzi kwizinkukhu futhi ingafaka izicubu zomzimba kanye namathambo). Ngaphandle kwe-cerebrospinal fluid, ukugxila kwezidakamizwa cishe kuzo zonke izicubu kuphakeme kunalokho nge-plasma. I-Hepatic metabolism ikakhulukazi ukususa iqembu le-ethyl lendandatho engu-7-piperazine ukukhiqiza i-ciprofloxacin, kulandelwe yi-oxidation kanye ne-glucoruronic acid conjugation. I-excrekwe ikakhulukazi yizinso (nge-tufration secreion kanye ne-filtration ye-tubular), futhi i-15% kuya ku-50% i-excreated ikhishwe ngaphandle komchamo. Ukuqedwa kwe-Half-Life of Lo mkhiqizo ngemuva kokuphathwa ngomlomo ngezinkukhu kungama-9.1 kuya ku-14.2 amahora
Ukusebenzisana kwezidakamizwa
(1) Lo mkhiqizo unomphumela we-synergistic ngokuhlanganiswa nama-aminloglycosides noma i-penicillin ebanzi.
I-Ion yensimbi esindayo enjenge-ca2 +, i-mg2 +, i-FE3 + ne-AL3 + ingabheka ngalo mkhiqizo futhi ithinte ukumuncwa.
.
.
(4) Isenzo nokusetshenziswa: Fluoroquinolone antibacterial izidakamizwa. Kusetshenziselwa izifo zamagciwane kanye nokutheleleka kwe-mycoplasma ezinkukhu.
Umthamo nokuphatha
Isiphuzo esixubile: 0.5 ~ 0.75 ml ngenkukhu nge-1 l yamanzi.
Ukuphendula Okubi
(1) Ukuwohloka kwe-cartilage kwenzeka ezilwaneni ezisencane, okuthinta ukuthuthukiswa kwamathambo nokubangela ubuhlungu nobuhlungu.
(2) Ukusabela kohlelo lokugaya kufaka phakathi ukulahleka kwesifiso sokudla, isifo sohudo, njll.
Izinyathelo zokuzivikela
Kuhlanganiswe ekubekeni izinkukhu ngesikhathi sokubeka
Isikhathi sokuhoxisa
I-Avian: Izinsuku eziyi-8
Ukubeka
Kuvaliwe futhi kugcinwe, kuvikelwe ukukhanya.
UHebei Veyong Pharmaceutical Co, Ltd, wasungulwa ngonyaka ka-2002, etholakala eShijiazhuang City, esifundeni saseHebei, eChina, eduze kwenhloko-dolobha eBeijing. Uyibhizinisi elikhulu lezidakamizwa eliqinisekisiwe le-GMP, nge-R & D, ukukhiqizwa kanye nokuthengiswa kwama-apis wezilwane, amalungiselelo, okuphakelayo okubekiwe kanye nokuphakelwa izengezo. Njengesikhungo sezobuchwepheshe sesifundazwe, uVeyong usungule uhlelo olusha lwe-R & D lwe-New Veterinary Drug, futhi yiwona we-technological annology ebhizinisini elisuselwa kubuchwepheshe, kukhona ochwepheshe bezobuchwepheshe abangama-65. UVeyong unezisekelo ezimbili zokukhiqiza: I-Shijuazhuang kanye ne-Ordos, lapho iShijuazhuange isiza ifaka indawo engu-78,706 m2, i-Oxytetracycline imigqa yokukhiqiza kubandakanya i-ivermectin, i-olytetracycline imigqa yokukhiqiza kubandakanya umjovo, i-bolus, ama-pesticides kanye amagciwane, amahlelo. UVeyong unikeza ama-API, amalungiselelo angaphezu kwe-100 anamalebula, kanye nensizakalo ye-OEM & ODM.
UVeyong unamathela ngokubaluleka okukhulu ekuphathweni kwe-EHS (imvelo, ezempilo kanye nokuphepha), futhi uthole izitifiketi ze-ISO14001 nezi- ohsas180000. UVeyong ubhalwe phansi kumabhizinisi wezimboni asafufusa izimboni esifundazweni saseHebei futhi angaqinisekisa ukunikezwa kwemikhiqizo okuqhubekayo.
UVeyong wasungula uhlelo oluphelele lokuphathwa kwekhwalithi, ethola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APHVMA GMP, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi sadlula ukuhlolwa kwe-US FDA. UVeyong uneqembu eliqeqeshiwe lokurejista, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukuthembela nokusekelwa okuvela kumakhasimende amaningi ngekhwalithi ephezulu yomkhiqizo, insizakalo ephezulu yokuthengisa kanye nokuthengisa okuthengiswayo, ukuphathwa okungathi sína. UVeyong wenze ukubambisana isikhathi eside ngamabhizinisi amaningi ezaziwayo ezingezemikhiqizo athunyelwe eYurophu, eSouth America, eMpumalanga Ephakathi, e-Eshiya, e-ESIA, amazwe angaphezu kwangu-60.
